Resmed (RMD) Notes Payables (2016 - 2025)
Historic Notes Payables for Resmed (RMD) over the last 11 years, with Q4 2025 value amounting to $259.9 million.
- Resmed's Notes Payables rose 252372.3% to $259.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $259.9 million, marking a year-over-year increase of 252372.3%. This contributed to the annual value of $9.9 million for FY2025, which is 0.0% changed from last year.
- Per Resmed's latest filing, its Notes Payables stood at $259.9 million for Q4 2025, which was up 252372.3% from $259.9 million recorded in Q3 2025.
- Over the past 5 years, Resmed's Notes Payables peaked at $259.9 million during Q4 2025, and registered a low of $9.9 million during Q3 2024.
- For the 5-year period, Resmed's Notes Payables averaged around $35.4 million, with its median value being $9.9 million (2022).
- In the last 5 years, Resmed's Notes Payables crashed by 1750.0% in 2022 and then skyrocketed by 252630.36% in 2025.
- Quarter analysis of 5 years shows Resmed's Notes Payables stood at $12.0 million in 2021, then decreased by 17.5% to $9.9 million in 2022, then dropped by 0.02% to $9.9 million in 2023, then increased by 0.08% to $9.9 million in 2024, then surged by 2523.72% to $259.9 million in 2025.
- Its Notes Payables stands at $259.9 million for Q4 2025, versus $259.9 million for Q3 2025 and $9.9 million for Q2 2025.